Mitokyne
Stage
Other Investors | AliveAbout Mitokyne
Mitokyne, founded in 2011, is acquired. It develops small molecule therapeutics to enhance mitochondrial function. The company's small molecule therapeutics help to improve mitochondria function and provide treatment for genetic, metabolic, and neurodegenerative disorders, as well as diseases and conditions of aging. It is based in Cambridge, Massachusetts.
Mitokyne Headquarter Location
1030 Massachusetts Avenue Suite 200
Cambridge, Massachusetts, 02138,
United States
Where is Mitokyne's headquarters?
Mitokyne's headquarters is located at 1030 Massachusetts Avenue, Cambridge.
What is Mitokyne's latest funding round?
Mitokyne's latest funding round is Other Investors.
Who are the investors of Mitokyne?
Investors of Mitokyne include Longwood Fund.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.